Frank A. Damelio

Executive

Director

Zoetis Inc.Pfizer Inc Hewlett Packard Enterprise Co Catalent, Inc.Viatris Inc

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 1 buy · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€428k

▼ Sales (0 ops.)

—

Latest filing published 11 Aug 2026 for Zoetis Inc.. Read the official filing

Filing timeline

BuySale

Frank A. Damelio

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Frank A. Damelio: trading record in brief

Frank A. Damelio (senior executive) discloses dealings in 5 companies, chiefly Catalent, Inc., Hewlett Packard Enterprise Co and Pfizer Inc. We count 13 filings; the first trade dates from 23 February 2022 and the latest from 7 August 2026.

No open-market sale appears; the market trades are 1 purchase worth €428k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants and 7 option exercises. So far in 2026, the count stands at 1 purchase and no sales.

The record was last updated on 11 August 2026 with a transaction in Zoetis Inc. The last insider purchase was made public on 13 May 2026, 158 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.